Arbore Giuseppina, Kemper Claudia
MRC Centre for Transplantation, Division of Transplant Immunology and Mucosal Biology, King's College London, London, UK.
Laboratory of Molecular Immunology and the Immunology Center, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD, USA.
Eur J Immunol. 2016 Jul;46(7):1563-73. doi: 10.1002/eji.201546131. Epub 2016 Jun 8.
The inflammasomes are intracellular multiprotein complexes that induce and regulate the generation of the key pro-inflammatory cytokines IL-1β and IL-18 in response to infectious microbes and cellular stress. The activation of inflammasomes involves several upstream signals including classic pattern or danger recognition systems such as the TLRs. Recently, however, the activation of complement receptors, such as the anaphylatoxin C3a and C5a receptors and the complement regulator CD46, in conjunction with the sensing of cell metabolic changes, for instance increased amino acid influx and glycolysis (via mTORC1), have emerged as additional critical activators of the inflammasome. This review summarizes recent advances in our knowledge about complement-mediated inflammasome activation, with a specific focus on a novel "complement - metabolism - NLRP3 inflammasome axis."
炎性小体是细胞内多蛋白复合物,可响应感染性微生物和细胞应激诱导并调节关键促炎细胞因子白细胞介素-1β(IL-1β)和白细胞介素-18(IL-18)的产生。炎性小体的激活涉及多个上游信号,包括经典模式或危险识别系统,如Toll样受体(TLRs)。然而,最近,补体受体的激活,如过敏毒素C3a和C5a受体以及补体调节蛋白CD46,与细胞代谢变化的感知(例如通过哺乳动物雷帕霉素靶蛋白复合物1(mTORC1)增加氨基酸流入和糖酵解)相结合,已成为炎性小体的额外关键激活因子。本综述总结了我们在补体介导的炎性小体激活方面的最新知识进展,特别关注一种新型的“补体-代谢-NLRP3炎性小体轴”。